Global and Humanitarian Medicine
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.
20 Jan, 2022 | 09:17h | UTCGlobal burden of bacterial antimicrobial resistance in 2019: a systematic analysis – The Lancet
Editorial: Antimicrobial resistance: time to repurpose the Global Fund – The Lancet
Commentary: Antimicrobial resistance now a leading cause of death worldwide, study finds – The Guardian
Commentary on Twitter
NEW—An estimated 1.2 million people died in 2019 from antibiotic-resistant bacterial infections, more deaths than HIV/AIDS or malaria.#GRAMPaper reveals the scale of antimicrobial resistance (#AMR), now a leading cause of death worldwide: https://t.co/2h5UEKemEq #AMRSOS pic.twitter.com/aWLhmdirJ8
— The Lancet (@TheLancet) January 20, 2022
1.8 million excess deaths attributable to urban air pollution in 2019, modelling study suggests.
20 Jan, 2022 | 09:13h | UTCNews Release: The Lancet Planetary Health: 1.8 million excess deaths attributable to urban air pollution in 2019, modelling study suggests
Related Studies:
Commentary on Twitter (thread – click for more)
NEW—Approx. 86% of people living in urban areas exposed to unhealthy particulate matter levels, leading to 1.8 million excess deaths in 2019: modelling study in @TheLancetPlanet. #AirPollutionhttps://t.co/kw34ANZ4ph
Thread 🧵 pic.twitter.com/QiRXU4QVHP
— The Lancet (@TheLancet) January 6, 2022
Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019.
13 Jan, 2022 | 08:42h | UTCInvited Commentary: The true global disease burden of mental illness: still elusive – The Lancet Psychiatry (free registration required)
A cluster randomized trial in a yaws-endemic area of Papua New Guinea showed a reduction in the community prevalence of yaws with three rounds of mass administration of azithromycin at 6-month intervals compared with one round of mass administration of azithromycin followed by two rounds of targeted treatment.
12 Jan, 2022 | 08:44h | UTCTrial of Three Rounds of Mass Azithromycin Administration for Yaws Eradication – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary on Twitter
Data from a community-based trial in Papua New Guinea suggest that more than one round of mass drug administration should be considered as part of the strategy for yaws eradication. https://t.co/7Cfuz16CUa pic.twitter.com/pVRyefOlTb
— NEJM (@NEJM) January 6, 2022
WHO: 10 key global health moments from 2021.
8 Jan, 2022 | 23:20h | UTC10 key global health moments from 2021 – World Health Organization
Commentary on Twitter (thread – click for more)
10 key global health moments from 2021 https://t.co/QYt8jV9WWh pic.twitter.com/ZPoM3zFPzI
— World Health Organization (WHO) (@WHO) December 21, 2021
RCT: Low-cost, easy to take antiretroviral treatment based on Dolutegravir as first- or second-Line therapy found to be non-inferior to standard care for treating HIV-1 infection in children.
8 Jan, 2022 | 23:07h | UTCDolutegravir as First- or Second-Line Treatment for HIV-1 Infection in Children – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: Easy-to-take medicine better at suppressing HIV in children – University College London
Commentaries on Twitter
Dolutegravir-based antiretroviral therapy was compared with standard care in children and adolescents starting first- or second-line therapy for HIV type 1 infection. Dolutegravir-based ART was superior to standard-care ART. https://t.co/PP0XaEVswO pic.twitter.com/pQvhjdXcUk
— NEJM (@NEJM) December 29, 2021
Visual Abstract: Dolutegravir as First- or Second-Line HIV Treatment in Children https://t.co/2RIg9uH2V1 pic.twitter.com/mDr1Z6l6CJ
— NEJM (@NEJM) January 4, 2022
WHO Reports | More than half a billion people pushed or pushed further into extreme poverty due to health care costs.
14 Dec, 2021 | 08:55h | UTCReport 1: Tracking Universal Health Coverage: 2021 Global monitoring report – World Health Organization
Report 2: Global monitoring report on financial protection in health 2021 – World Health Organization
WHO Report: More malaria cases and deaths in 2020 linked to COVID-19 disruptions.
7 Dec, 2021 | 08:55h | UTCNews Release: More malaria cases and deaths in 2020 linked to COVID-19 disruptions – World Health Organization
Report: World Malaria Report 2021 – World Health Organization
Commentaries:
More people died of malaria in 2020 than in 2019. Here’s why – NPR
Malaria kills 180,000 more people annually than previously thought, says WHO – The Guardian
Commentary on Twitter (thread – click for more)
#COVID19 pandemic has disrupted #malaria services, leading to a marked increase in cases and deaths: 14 million more cases in 2020 compared to 2019, and 69,000 more deaths – new report.
➡️https://t.co/M9sNo2Pn4u #EndMalaria pic.twitter.com/g6MKFVpQKf— World Health Organization (WHO) (@WHO) December 6, 2021
The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019.
5 Dec, 2021 | 23:09h | UTCInvited Commentary: Burden of cancer in adolescents and young adults – The Lancet Oncology
Global estimates of viral suppression in 31 countries shows too many people with HIV fail to achieve durable viral suppression.
1 Dec, 2021 | 08:41h | UTCNews Release: Too many people with HIV fail to achieve durable viral suppression – NIH News Releases
Original Study: Global estimates of viral suppression in children and adolescents and adults on antiretroviral therapy adjusted for missing viral load measurements: a multiregional, retrospective cohort study in 31 countries – The Lancet HIV (link to abstract – $ for full-text)
Review: Prevention of emerging infections in children.
23 Nov, 2021 | 08:17h | UTCPrevention of Emerging Infections in Children – Pediatric Clinics of North America
[Not published yet] Single-dose HPV vaccine highly effective, researchers say – “Results of randomized controlled trial in Kenya bring new energy to eliminate cervical cancer worldwide”.
21 Nov, 2021 | 22:56h | UTCRelated:
Three-year follow-up of 2-dose versus 3-dose HPV vaccine
CDC: 92% of Human Papillomavirus–Attributable Cancers can be Targeted by HPV Vaccination
Meta-Analysis: Population-level Impact of HPV Vaccination Programs
Global tuberculosis progress reversed by COVID-19 pandemic.
19 Nov, 2021 | 10:51h | UTCGlobal tuberculosis progress reversed by COVID-19 pandemic – The Lancet Respiratory Diseases
Related:
How COVID is derailing the fight against HIV, TB and malaria.
How COVID hurt the fight against other dangerous diseases
World TB Day | Report: COVID-19 Eliminates Twelve Years of Progress Against Tuberculosis
Tuberculosis and Covid-19: Fighting a deadly syndemic
Commentary on Twitter
NEWS—Global #tuberculosis progress reversed by #COVID19 pandemic
"Due to the delayed effects from #COVID19, #tuberculosis deaths are projected to rise again in 2022 while the world readjusts to a new normality and services resume."
Read more here: https://t.co/tWVXswZsvs
— The Lancet Respiratory Medicine (@LancetRespirMed) November 3, 2021
New WHO report maps barriers to insulin availability and suggests actions to promote universal access – “100 years after its discovery, insulin still out of reach for many living with diabetes”.
16 Nov, 2021 | 08:34h | UTCReport: Keeping the 100-year-old promise: making insulin access universal – World Health Organization
Commentary: Half the People Living with Diabetes Can’t Afford Insulin, WHO Report Shows – Health Policy Watch
Related:
Editorial | Insulin for all: a hope yet to be realized.
One hundred years of insulin therapy.
Commentary on Twitter (thread – click for more)
https://twitter.com/WHO/status/1459194472022122500
#AHA21 – RCT: Among children and adolescents who had screening echocardiograms and were identified as having latent rheumatic heart disease, secondary antibiotic prophylaxis with penicillin G benzathine for 2 years was associated with reduced echocardiographic progression (0.8 vs. 8.2% in the control group).
14 Nov, 2021 | 20:03h | UTCSecondary Antibiotic Prophylaxis for Latent Rheumatic Heart Disease – New England Journal of Medicine (link to abstract – $ for full-text)
Commentaries:
Secondary Antibiotic Prophylaxis for Latent Rheumatic Heart Disease – American College of Cardiology
Commentaries on Twitter
One of most important studies ever Rheumatic Heart Disease @NEJM https://t.co/U8FuNHLqCJ RCT evidence 2ry prophylaxis reduces progression latent RhD pic.twitter.com/UycTElr7QM
— Michael Marks (@dr_michaelmarks) November 13, 2021
Penicillin slowed the devastating impact of rheumatic heart disease among children in Uganda. Findings of a large-scale, randomized controlled trial were completed in Uganda. Group A strep underlies rheumatic heart disease. New England Journal of Medicine https://t.co/1PKFJ12FvC
— delthia ricks 🔬 (@DelthiaRicks) November 13, 2021
Extreme heat is broiling people in developing cities: New analysis finds the explosive growth of cities is helping drive dangerous conditions.
24 Oct, 2021 | 23:34h | UTCExtreme heat is broiling people in developing cities – Science
Original Study: Global urban population exposure to extreme heat – Proceedings of the National Academy of Sciences
Commentary on Twitter
People in major cities are exposed to deadly temperatures 3X more often than in the 1980s—with cities in South Asia, Africa, and the Middle East bearing the brunt, according to a new analysis of 13,000+ cities. https://t.co/C864clE4Cq
— Global Health NOW (@ghn_news) October 9, 2021
Health care–acquired infections in low- and middle-income countries and the role of infection prevention and control.
22 Oct, 2021 | 10:09h | UTC
WHO Report: Tuberculosis deaths rise for the first time in more than a decade due to the COVID-19 pandemic.
15 Oct, 2021 | 02:30h | UTCReport: Global tuberculosis report 2021
Commentary: Tuberculosis deaths rise for 1st time in years, due to COVID – Associated Press
Commentary on Twitter (thread – click for more)
🆕 WHO's Global TB Report reveals deaths from #tuberculosis rise for the first time in more than a decade due to the #COVID19 pandemic.
1.5 million people died in 2020 & the number will continue to rise unless urgent action is taken 👉https://t.co/RFmWYIelhq #EndTB pic.twitter.com/33G7sI8K2J
— World Health Organization (WHO) (@WHO) October 14, 2021
Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 and 2018.
13 Oct, 2021 | 01:21h | UTCInvited commentary: Anemia in women — an intractable problem that requires innovative solutions – Nature Medicine
WHO report highlights global shortfall in investment in mental health.
10 Oct, 2021 | 21:39h | UTCWHO report highlights global shortfall in investment in mental health – World Health Organization
Report: Mental Health ATLAS 2020 – World Health Organization
Commentary on Twitter (thread – click for more)
The world has failed to provide people with the #MentalHealth services they need: new Mental Health Atlas
Read more➡️https://t.co/J0uKvKWZ46 pic.twitter.com/0wKx6JTV2F— World Health Organization (WHO) (@WHO) October 8, 2021
Systematic Review: Administration of antimalarial drugs to whole populations for reducing malaria.
7 Oct, 2021 | 10:36h | UTCAdministration of antimalarial drugs to whole populations for reducing malaria – Cochrane Library
Original study: Mass drug administration for malaria – Cochrane Library
Commentary on Twitter
https://twitter.com/CochraneUK/status/1444724442094088195
WHO approves first ever malaria vaccine for children at risk.
7 Oct, 2021 | 10:40h | UTCWHO recommends groundbreaking malaria vaccine for children at risk – World Health Organization
Commentaries:
WHO Approves First Ever Malaria Vaccine – Health Policy Watch
In major decision, WHO recommends broad rollout of world’s first malaria vaccine – STAT
Why the WHO approval of the first malaria vaccine is a big deal – Vox
WHO greenlights the world’s first malaria vaccine — but it’s not a perfect shot – NPR
The World Health Organization Just Endorsed The World’s First Malaria Vaccine – TIME
WHO Backs Widespread Use Of First Malaria Vaccine – Forbes
World’s 1st malaria vaccine recommended by WHO – LiveScience
Commentaries on Twitter
I started my career as a #malaria researcher, and I longed for the day that we would have an effective vaccine against this ancient and terrible disease. Today is that day: @WHO is recommending the broad use of the world’s first malaria vaccine. #EndMalaria https://t.co/Oh1O155tYj
— Tedros Adhanom Ghebreyesus (@DrTedros) October 6, 2021
(thread – click for more)
A child dies from #malaria every two minutes.
One death is one too many.🚨 Today, WHO recommends RTS,S, a groundbreaking malaria vaccine, to reduce child illness & deaths in areas with moderate and high malaria transmission https://t.co/xSk58nTIV1#VaccinesWork pic.twitter.com/mSECLtRhQs
— World Health Organization (WHO) (@WHO) October 6, 2021
The Lancet Commission: transforming access to diagnostics.
7 Oct, 2021 | 10:33h | UTCNews release: The Lancet: Half of the global population lack access to basic diagnostics for many common diseases
Video: Transforming access to diagnostics | The Lancet Commission on diagnostics
Homepage: The Lancet Commission on diagnostics: transforming access to diagnostics
The Lancet Commission on diagnostics: transforming access to diagnostics (free registration required)
Transforming access to diagnostics: how to turn good intentions into action? (free registration required)
Can COVID-19 help accelerate and transform the diagnostics agenda?
Commentary: A Grim Diagnosis – Half The World’s Population Has Limited Access To Diagnostics – Forbes
Related:
WHO Updates Global Guidance on Medicines and Diagnostic Tests
The WHO Essential Diagnostic List: A Tool for the Future
Perspective: Health Care is an Essential Human Right – And So Is a Proper Diagnosis
Report: First-ever WHO List of Essential Diagnostic Tests
Commentary on Twitter
https://twitter.com/DiagnosticsCom/status/1445879305536483332
Supplement: Triumphs of Vaccination.
6 Oct, 2021 | 08:55h | UTCHomepage: Triumphs of Vaccination – The Journal of Infectious Diseases
Hib Vaccines: Their Impact on Haemophilus influenzae Type b Disease
The Rotavirus Vaccine Story: From Discovery to the Eventual Control of Rotavirus Disease
Triumph of Pneumococcal Conjugate Vaccines: Overcoming a Common Foe
Rubella Eradication: Not Yet Accomplished, but Entirely Feasible
Live Attenuated Varicella Vaccine: Prevention of Varicella and of Zoster
Immunization Against Poliomyelitis and the Challenges to Worldwide Poliomyelitis Eradication
Influenza Vaccines: Successes and Continuing Challenges
Measles in the 21st Century: Progress Toward Achieving and Sustaining Elimination
Overview of the United States’ Immunization Program
The World of Immunization: Achievements, Challenges, and Strategic Vision for the Next Decade
WHO prioritizes access to diabetes and cancer treatments in new Essential Medicines Lists.
3 Oct, 2021 | 22:46h | UTCNews Release: WHO prioritizes access to diabetes and cancer treatments in new Essential Medicines Lists – World Health Organization
Report: WHO model list of essential medicines – 22nd list, 2021 – World Health Organization
Commentary: For the first time, WHO committee recommends action on high-priced essential medicines – STAT
Commentary on Twitter (thread – click for more)
🆕 WHO 2021 Essential Medicines Lists have 20 new medicines for adults & 17 for children, incl. insulin analogues, new oral medicines for diabetes & medicines for cancer treatment https://t.co/LfWwHEZtuM pic.twitter.com/HMFOP8ioBf
— World Health Organization (WHO) (@WHO) October 1, 2021